The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer
肿瘤靶向免疫细胞因子 F16-IL2 与阿霉素联合使用:在晚期实体瘤患者中增加剂量并扩展到转移性乳腺癌患者
期刊:Cell Adhesion & Migration
影响因子:3.3
doi:10.4161/19336918.2014.983785
Chiara Catania, Michela Maur, Rossana Berardi, Andrea Rocca, Anna Maria Di Giacomo, Gianluca Spitaleri, Cristina Masini, Chiara Pierantoni, Reinerio González-Iglesias, Giulia Zigon, Annaelisa Tasciotti, Leonardo Giovannoni, Valeria Lovato, Giuliano Elia, Hans D Menssen, Dario Neri, Stefano Cascinu,